IN THE NEWS

THE LATEST NEWS

BioCentury Article Highlights GNS Discoveries on Behalf of The MMRF

GenomeWeb Article Offers Insight on GNS-Celgene Deal and Growing Demand for Causal Modeling

Outsourcing Pharma Puts Spotlight on Power of Causality, Highlights GNS-Celgene Deal Licensing REFS

Discoveries by GNS Healthcare Causal Machine Learning and Simulation Platform, REFS, Reveal Mechanisms Driving Key Clinical Outcomes in Multiple Myeloma

Celgene Enters Into Service and License Arrangement for GNS Healthcare’s Causal Machine Learning Platform to Accelerate Value-Based and Precision Medicine Development

MS News Today Features GNS ‘Efficacy to Effectiveness’ Solution

GNS REFS™ Causal Machine Learning Platform Featured in GEN (Genetic Engineering & Biotechnology News)

BioTelemetry, Inc. (NASDAQ:BEAT) Appoints Colin Hill to Board of Directors

GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes

CNBC’s Squawk Box Calls on GNS CEO Colin Hill to Understand Use of Big Data in Employee Wellness